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OBJECTIVE — To examine cross-sectional associations of serum vitamin D [25-
hydroxyvitamin D, 25(OH)D] concentration with insulin resistance (IR) and -cell dysfunction
in 712 subjects at risk for type 2 diabetes.
RESEARCH DESIGN AND METHODS — Serum 25(OH)D was determined using a
chemiluminescence immunoassay. Insulin sensitivity/resistance were measured using the Mat-
suda insulin sensitivity index for oral glucose tolerance tests (ISOGTT) and homeostasis model
assessment of insulin resistance HOMA-IR. -Cell function was determined using both the
insulinogenic index (IGI) divided by HOMA-IR (IGI/IR) and the insulin secretion sensitivity
index-2 (ISSI-2).
RESULTS — Linear regression analyses indicated independent associations of 25(OH)D with
ISOGTTandHOMA-IR(0.004,P0.0003,and0.003,P0.0072,respectively)and
with IGI/IR and ISSI-2 (0.004, P  0.0286, and 0.003, P  0.0011, respectively) after
adjusting for sociodemographics, physical activity, supplement use, parathyroid hormone, and
BMI.
CONCLUSIONS — Vitamin D may play a role in the pathogenesis of type 2 diabetes, as
25(OH)D concentration was independently associated with both insulin sensitivity and -cell
function among individuals at risk of type 2 diabetes.
Diabetes Care 33:1379–1381, 2010
E
merging evidence suggests a role for
vitamin D in the etiology of type 2
diabetes (1). However, associations
of vitamin D with insulin resistance (IR)
and especially -cell dysfunction have
been inconsistent (2–7). Therefore, our
objective was to assess the association of
serum vitamin D concentration with IR
and -cell dysfunction in a large, ethni-
cally-diverse, North American cohort at
risk of type 2 diabetes.
RESEARCH DESIGN AND
METHODS— A detailed methodol-
ogy for this study has been described pre-
viously (8). Brieﬂy, participants in the
PROspective Metabolism and ISlet cell
Evaluation (PROMISE) cohort were re-
cruited from Toronto and London, On-
tario, Canada, from 2004 to 2006.
Participants were 30 years of age and
older and at high risk for type 2 diabetes
and/or metabolic syndrome (8). The cur-
rent study includes 712 subjects, 92% of
whom were free of diabetes based on oral
glucose tolerance tests (OGTTs). None
had known diabetes at the time of the
assessments.
Fasting blood samples were collected
and75-gOGTTswereperformed.Insulin
sensitivity was quantiﬁed using the Mat-
suda insulin sensitivity index for oral glu-
cose tolerance tests (ISOGTT) (9), and IR
was measured using the homeostasis
model assessment of insulin resistance
(HOMA-IR) index (10). -cell dysfunc-
tionwasdeterminedbydividingtheinsu-
linogenic index (IGI) by HOMA-IR (IGI/
IR) (11) and by calculating the insulin
secretion sensitivity index-2 (ISSI-2)
(12).
Serum vitamin D, speciﬁcally 25-
hydroxyvitamin D [25(OH)D], was mea-
sured using DiaSorin’s “25-OH vitamin D
TOTAL” competitive chemiluminescence
immunoassay on an automated LIAISON
analyzer (Stillwater, MN). BMI and waist
circumference were determined using
standardized procedures (8). Parathyroid
hormone (PTH) was measured using an
electrochemiluminescence immunoassay
ontheRocheModularE170analyzer(La-
val, QC). Structured questionnaires as-
sessed self-reported ethnicity, smoking
and physical activity, and included an
open-ended question on current medica-
tion and supplement use. Season was de-
ﬁned using the participant’s date of
clinical assessment and categorized as
May–October (summer/early fall) and
November–April (winter/early spring).
SAS Version 9.1 (Cary, NC) was used
forallanalyses.Naturallogarithmictrans-
formations were applied for all non-
normallydistributedvariables.Univariate
analyses, including 
2 tests, analysis of
variance (ANOVA), and Spearman corre-
lation were conducted to assess the rela-
tionship between serum 25(OH)D and
potential covariates. Multiple linear re-
gression analyses were conducted to in-
vestigate the independent associations of
25(OH)D with measures of insulin sensi-
tivity/resistance (ISOGTT and HOMA-IR)
and -cell dysfunction (IGI/IR and ISSI-
2). Model 1 adjusted for sex, age, ethnic-
ity and season; model 2 additionally
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cal activity and PTH; and model 3 addi-
tionally adjusted for BMI. Possible effect
modiﬁers were also investigated.
RESULTS— Thesampleincluded498
(69.9%) females and 462 (64.9%) Cauca-
sians,andthemeanageoftheparticipants
was 49.6  10.0 years. The mean serum
25(OH)D concentration was 55.81 
22.90 nmol/l (range 10.0–161.0). Partic-
ipant characteristics across quartiles of
25(OH)D concentration and correlations
for continuous variables are presented
(online Table A1, available in an online
appendix at http://care.diabetesjournals.
org/content/full/dc09-2321/DC1). A sig-
niﬁcant seasonal effect was evident, with
higher 25(OH)D concentrations in the
summer/early fall (n  343; 59.11 
23.71 nmol/l) than in the winter/early
spring (n  351; 52.58  21.64 nmol/l)
(P  0.0002). Univariate analyses indi-
cated a signiﬁcant positive association be-
tween 25(OH)D and ISOGTT (r  0.30,
P  0.0001), a signiﬁcant negative asso-
ciation between 25(OH)D and HOMA-IR
(r  0.29, P  0.0001), as well as sig-
niﬁcant positive associations between
25(OH)D and IGI/IR (r  0.14, P 
0.0002) and ISSI-2 (r  0.14, P 
0.0002).
In multivariate regression analyses,
serum 25(OH)D was a signiﬁcant inde-
pendent predictor of insulin sensitivity
(ISOGTT and HOMA-IR) and -cell func-
tion (IGI/IR and ISSI-2) across all models
(Table 1). There was a slight attenuation
of the association of 25(OH)D on mea-
sures of insulin sensitivity and -cell
function after additional adjustment for
BMI, but the association remained
signiﬁcant.
We found a signiﬁcant interaction by
BMI, reﬂecting weaker magnitudes of as-
sociation of 25(OH)D with measures of
insulin sensitivity and -cell function in
obese individuals (BMI 30 kg/m
2) (on-
line Table A2).
CONCLUSIONS— This study dem-
onstrated independent associations of
25(OH)D with both insulin sensitivity
and -cell function in subjects without
known diabetes, the majority of whom
were free of diabetes based on OGTTs.
Themajorcontributionofthisstudyisthe
ﬁnding of an association between vitamin
D and -cell function. Previous studies
assessing the association between
25(OH)D and -cell function have
yielded inconsistent results (2–4,13,14),
possibly resulting from small sample
sizes, the use of indirect measures of
-cell function (i.e., primarily fasting
based measures), and/or the lack of ad-
justment for background IR. In contrast,
our study found a signiﬁcant positive as-
sociation between vitamin D and -cell
function, using validated measures of
-cell function which account for the hy-
perbolic relationship between insulin se-
cretion and insulin sensitivity (12).
Although an inverse association be-
tween 25(OH)D and IR has been ob-
served in previous studies (3–5,7), the
majority of these studies relied primarily
on simple fasting-based measures and
mostdidnotadjustforphysicalactivityor
PTH. In addition, negative ﬁndings have
been reported, even when more direct
measures of insulin sensitivity were used
(2,6). Possible reasons for this discrep-
ancy in ﬁndings may be due to small
sample sizes or differences in study pop-
ulations. The negative ﬁndings of Gulseth
et al. (2) among those with the metabolic
syndrome may be attributable to the se-
questering of 25(OH)D in adipose tissue
(15), resulting in reduced bioavailability
of 25(OH)D. Similarly, we found a
weaker association of vitamin D with IR
and -cell function in those with a BMI
30 kg/m
2.
Strengthsofthecurrentstudyinclude
themeasurementofserum25(OH)Dcon-
centration, as well as the use of validated
measures of both IR and -cell dysfunc-
tion. In addition, the current study in-
cluded a large, well-characterized multi-
ethnic sample. Limitations include the
cross-sectional design, and the lack of
“gold standard” measures of IR and -cell
function, which are invasive and costly to
use in large studies. Lastly, 25(OH)D was
measured in blood samples obtained
acrossdifferentseasons,althoughwecon-
trolled for a seasonal effect and assessed
potential interactions.
In conclusion, vitamin D was signiﬁ-
cantly related to IR and -cell function in
a multi-ethnic sample at risk for type 2
diabetes. Further research is needed on
the prospective association between vita-
min D and the underlying disorders of
type 2 diabetes in large population-based
studies.
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